Singular Genomics Systems, Inc. (OMIC)
USD 19.6
(-0.56%)
USD 19.6
(-0.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -86.49 Million USD | 4.02% |
| 2022 | -84.08 Million USD | -48.84% |
| 2021 | -60.54 Million USD | -129.43% |
| 2020 | -26.39 Million USD | -120.71% |
| 2019 | -11.95 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -22.8 Million USD | 16.64% |
| 2024 Q1 | -25.12 Million USD | -8.03% |
| 2023 Q3 | -20.2 Million USD | 13.75% |
| 2023 FY | - USD | 4.02% |
| 2023 Q4 | -21.3 Million USD | -5.46% |
| 2023 Q2 | -23.42 Million USD | -8.67% |
| 2023 Q1 | -21.55 Million USD | -3.35% |
| 2022 Q2 | -22.27 Million USD | -7.28% |
| 2022 Q1 | -20.76 Million USD | -6.11% |
| 2022 FY | - USD | -48.84% |
| 2022 Q4 | -20.85 Million USD | 4.81% |
| 2022 Q3 | -21.91 Million USD | 1.62% |
| 2021 FY | - USD | -129.43% |
| 2021 Q4 | -19.56 Million USD | -14.6% |
| 2021 Q3 | -17.07 Million USD | -29.2% |
| 2021 Q1 | -9.92 Million USD | -34.97% |
| 2021 Q2 | -13.21 Million USD | -33.22% |
| 2020 FY | - USD | -120.71% |
| 2020 Q4 | -7.35 Million USD | 2.14% |
| 2020 Q3 | -7.51 Million USD | -16.04% |
| 2020 Q2 | -6.47 Million USD | -28.03% |
| 2020 Q1 | -5.05 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | -89.551% |
| AngioDynamics, Inc. | -14.29 Million USD | -505.206% |
| AtriCure, Inc. | -8.1 Million USD | -966.667% |
| Avinger, Inc. | -16.34 Million USD | -429.157% |
| Azenta, Inc. | 55.15 Million USD | 256.835% |
| BioLife Solutions, Inc. | -45.23 Million USD | -91.202% |
| The Cooper Companies, Inc. | 882.8 Million USD | 109.798% |
| Daxor Corporation | 329.74 Thousand USD | 26331.576% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | -555.372% |
| Femasys Inc. | -13.16 Million USD | -556.795% |
| GlucoTrack, Inc. | -7.09 Million USD | -1119.8% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 1011.156% |
| Hologic, Inc. | 1.29 Billion USD | 106.673% |
| ICU Medical, Inc. | 307.69 Million USD | 128.111% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 103.613% |
| KORU Medical Systems, Inc. | -9.39 Million USD | -820.21% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 276.558% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -1215.502% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -1215.502% |
| Masimo Corporation | 236.7 Million USD | 136.542% |
| Microbot Medical Inc. | -10.63 Million USD | -713.391% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 648.465% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 137.373% |
| Nephros, Inc. | -1.37 Million USD | -6172.371% |
| NovoCure Limited | -175.86 Million USD | 50.817% |
| NEXGEL, Inc. | -2.73 Million USD | -3068.352% |
| NEXGEL, Inc. | -2.73 Million USD | -3068.352% |
| OraSure Technologies, Inc. | 76.15 Million USD | 213.574% |
| Pro-Dex, Inc. | 8.33 Million USD | 1137.994% |
| Pulse Biosciences, Inc. | -42.36 Million USD | -104.159% |
| Predictive Oncology Inc. | -13.18 Million USD | -556.167% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -3343.379% |
| QuidelOrtho Corporation | 545.6 Million USD | 115.853% |
| Repligen Corporation | 124.29 Million USD | 169.591% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -29819.37% |
| STAAR Surgical Company | 33.22 Million USD | 360.365% |
| Sharps Technology, Inc. | -8.98 Million USD | -863.165% |
| Utah Medical Products, Inc. | 24.8 Million USD | 448.704% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 137.283% |
| Jin Medical International Ltd. | 3.44 Million USD | 2612.312% |